Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Ovarian Neoplasms

  Free Subscription


Articles published in Hum Pathol

Retrieve available abstracts of 38 articles:
HTML format
Text format



Single Articles


    September 2017
  1. XING D, Rahmanto YS, Zeppernick F, Hannibal CG, et al
    Mutation of NRAS is a Rare Genetic Event in Ovarian Low-Grade Serous Carcinoma.
    Hum Pathol. 2017 Sep 2. pii: S0046-8177(17)30303.
    PubMed     Text format     Abstract available


    July 2017
  2. RUSSO M, Broach J, Sheldon K, Houser KR, et al
    Clonal Evolution in Paired Endometrial Intraepithelial Neoplasia/Atypical Hyperplasia and Endometrioid Adenocarcinoma.
    Hum Pathol. 2017 Jul 13. pii: S0046-8177(17)30244.
    PubMed     Text format     Abstract available


  3. SCHOOLMEESTER JK, Moyer AM, Goodenberger ML, Keeney GL, et al
    Pathologic Findings in Breast, Fallopian Tube and Ovary Specimens in non-BRCA Hereditary Breast and/or Ovarian Cancer Syndromes: A Study of 18 Patients with Deleterious Germline Mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH or CHEK2.
    Hum Pathol. 2017 Jul 11. pii: S0046-8177(17)30240.
    PubMed     Text format     Abstract available


    April 2017
  4. ROTH LM, Lyu B, Cheng L
    Perspectives on testicular sex cord-stromal tumors and those composed of both germ cells and sex cord-stromal derivatives with a comparison to corresponding ovarian neoplasms.
    Hum Pathol. 2017 Apr 23. pii: S0046-8177(17)30125.
    PubMed     Text format     Abstract available


  5. AMAN M, Ohishi Y, Imamura H, Shinozaki T, et al
    Expression of protease-activated receptor-2 (PAR-2) is related to advanced clinical stage and adverse prognosis in ovarian clear cell carcinoma.
    Hum Pathol. 2017 Apr 21. pii: S0046-8177(17)30123.
    PubMed     Text format     Abstract available


  6. KIM WY, Shim SH, Jung HY, Dong M, et al
    The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
    Hum Pathol. 2017 Apr 17. pii: S0046-8177(17)30108.
    PubMed     Text format     Abstract available


  7. TAUBE ET, Denkert C, Sehouli J, Unger U, et al
    Cytokeratin 5/6 expression, prognosis and association with ER-alpha in high-grade serous ovarian carcinoma.
    Hum Pathol. 2017 Apr 13. pii: S0046-8177(17)30105.
    PubMed     Text format     Abstract available


  8. HAREL-DASSA K, Yedgar S, Trope CG, Davidson B, et al
    Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma.
    Hum Pathol. 2017;62:115-121.
    PubMed     Text format     Abstract available


    February 2017
  9. RAWISH KR, Desouki MM, Fadare O
    Atypical Mucinous Glandular Proliferations in Endometrial Samplings: Follow-Up and Other Clinicopathologic Findings In 41 cases.
    Hum Pathol. 2017 Feb 20. pii: S0046-8177(17)30048.
    PubMed     Text format     Abstract available


  10. BRONER EC, Trope CG, Reich R, Davidson B, et al
    TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma.
    Hum Pathol. 2017;60:180-187.
    PubMed     Text format     Abstract available


    December 2016
  11. ROSSI ED, Bizzarro T, Monterossi G, Inzani F, et al
    Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components.
    Hum Pathol. 2016 Dec 29. pii: S0046-8177(16)30357.
    PubMed     Text format     Abstract available


    November 2016
  12. PELLETIER MP, Trinh VQ, Stephenson P, Mes-Masson AM, et al
    Microcystic, elongated and fragmented (MELF) pattern invasion is mainly associated with isolated tumor cell pattern metastases in FIGO grade I endometrioid endometrial cancer (EEC).
    Hum Pathol. 2016 Nov 15. pii: S0046-8177(16)30306.
    PubMed     Text format     Abstract available


  13. WANG Y, Li M, Meng F, Lou G, et al
    HPIP Expression Predicts Chemoresistance and Poor Clinical Outcomes in Patients with epithelial ovarian cancer.
    Hum Pathol. 2016 Nov 3. pii: S0046-8177(16)30286.
    PubMed     Text format     Abstract available


    October 2016
  14. ZHANG C, Sung CJ, Quddus MR, Simon RA, et al
    Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: A clinicopathologic study of 238 cases.
    Hum Pathol. 2016 Oct 13. pii: S0046-8177(16)30245.
    PubMed     Text format     Abstract available


    September 2016
  15. KATO N, Kusumi T, Kamataki A, Tsunoda R, et al
    DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: A potential association with androgenic effects.
    Hum Pathol. 2016 Sep 21. pii: S0046-8177(16)30213.
    PubMed     Text format     Abstract available


  16. SCHOLZ B, Beckert M, Mordstein V, Hohmann N, et al
    Seromucinous borderline tumor of the testis-a case report.
    Hum Pathol. 2016 Sep 2. pii: S0046-8177(16)30206.
    PubMed     Text format     Abstract available


    June 2016
  17. LIANG L, Jiang Y, Chen JS, Niu N, et al
    B7-H4 Expression in Ovarian Serous Carcinoma: A Study of 306 Cases.
    Hum Pathol. 2016 Jun 24. pii: S0046-8177(16)30129.
    PubMed     Text format     Abstract available


  18. PASCUAL-GARCIA M, Bertolo C, Nieto JC, Serrat N, et al
    CD8 down-regulation on cytotoxic T lymphocytes of patients with endometrioid endometrial carcinomas.
    Hum Pathol. 2016 Jun 23. pii: S0046-8177(16)30124.
    PubMed     Text format     Abstract available


  19. WANG WC, Lai YC
    Genetic analysis results of mature cystic teratomas of the ovary in Taiwan disagree with the previous origin theory of this tumor.
    Hum Pathol. 2016;52:128-35.
    PubMed     Text format     Abstract available


    May 2016
  20. LIANG L, Huang H, Dadhania V, Zhang J, et al
    Renal cell carcinoma metastatic to the ovary or fallopian tube: a clinicopathological study of 9 cases.
    Hum Pathol. 2016;51:96-102.
    PubMed     Text format     Abstract available


  21. ANDRICI J, Jung J, Sheen A, D'Urso L, et al
    Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma.
    Hum Pathol. 2016;51:9-15.
    PubMed     Text format     Abstract available


    April 2016
  22. GUPTA M, Babic A, Beck AH, Terry K, et al
    TNF-alpha expression, risk factors, and inflammatory exposures in ovarian cancer: evidence for an inflammatory pathway of ovarian carcinogenesis?
    Hum Pathol. 2016 Apr 8. pii: S0046-8177(16)30018.
    PubMed     Text format     Abstract available


  23. JIA W, Dong Y, Tao L, Pang L, et al
    MAP3K3 overexpression is associated with poor survival in ovarian carcinoma.
    Hum Pathol. 2016;50:162-9.
    PubMed     Text format     Abstract available


    February 2016
  24. LIN X, Wu BB, Xing QY, Wang SD, et al
    PAX8, auseful biomarker for ovarianserous tumors.
    Hum Pathol. 2016 Feb 19. pii: S0046-8177(16)00051.
    PubMed     Text format    


  25. MOINUDDIN I, Bala A, Ali B, Khan H, et al
    Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma.
    Hum Pathol. 2016;48:163-6.
    PubMed     Text format     Abstract available


    October 2015
  26. DAVIDSON B, Holth A, Hellesylt E, Hadar R, et al
    HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival.
    Hum Pathol. 2015 Oct 22. pii: S0046-8177(15)00389.
    PubMed     Text format     Abstract available


    July 2015
  27. ADLER E, Mhawech-Fauceglia P, Gayther SA, Lawrenson K, et al
    PAX8 expression in ovarian surface epithelial cells.
    Hum Pathol. 2015;46:948-56.
    PubMed     Text format     Abstract available


    June 2015
  28. KATZ B, Trope CG, Reich R, Davidson B, et al
    MicroRNAs in Ovarian Cancer.
    Hum Pathol. 2015 Jun 30. pii: S0046-8177(15)00218.
    PubMed     Text format     Abstract available


  29. FATA CR, Seeley EH, Desouki MM, Du L, et al
    Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis.
    Hum Pathol. 2015 Jun 23. pii: S0046-8177(15)00214.
    PubMed     Text format     Abstract available


  30. JIANG G, Yang D, Wang L, Zhang X, et al
    A novel biomarker ARMc8 promotes the malignant progression of ovarian cancer.
    Hum Pathol. 2015 Jun 16. pii: S0046-8177(15)00209.
    PubMed     Text format     Abstract available


  31. IMAMURA H, Ohishi Y, Aman M, Shida K, et al
    Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor.
    Hum Pathol. 2015 Jun 16. pii: S0046-8177(15)00207.
    PubMed     Text format     Abstract available


    May 2015
  32. ZHANG J, Tang L, Chen Y, Duan Z, et al
    Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Hum Pathol. 2015 May 30. pii: S0046-8177(15)00190.
    PubMed     Text format     Abstract available


    April 2015
  33. CIUCCI A, Zannoni GF, Travaglia D, Scambia G, et al
    Mitochondrial estrogen receptor beta2 drives antiapoptotic pathways in advanced serous ovarian cancer.
    Hum Pathol. 2015 Apr 15. pii: S0046-8177(15)00120.
    PubMed     Text format     Abstract available


  34. IWAMOTO M, Nakatani Y, Fugo K, Kishimoto T, et al
    Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
    Hum Pathol. 2015 Apr 11. pii: S0046-8177(15)00109.
    PubMed     Text format     Abstract available


    March 2015
  35. XU B, Sun D, Wang Z, Weng H, et al
    Expression of LATS family proteins in ovarian tumors and its significance.
    Hum Pathol. 2015 Mar 5. pii: S0046-8177(15)00078.
    PubMed     Text format     Abstract available


  36. DE KOCK L, Druker H, Weber E, Hamel N, et al
    Ovarian embryonal rhabdomyosarcoma is a rare manifestation of the DICER1 syndrome.
    Hum Pathol. 2015 Mar 5. pii: S0046-8177(15)00074.
    PubMed     Text format     Abstract available


    February 2015
  37. DESMEULES P, Trudel D, Turcotte S, Sirois J, et al
    Prognostic significance of TIMP-2, MMP-2, and MMP-9 on high-grade serous ovarian carcinoma using digital image analysis.
    Hum Pathol. 2015 Feb 12. pii: S0046-8177(15)00040.
    PubMed     Text format     Abstract available


    January 2015
  38. CARLETON C, Houghton OP, McCluggage WG
    Juvenile granulosa cell tumor arising in ovarian adenosarcoma: an unusual form of sarcomatous overgrowth.
    Hum Pathol. 2015 Jan 7. pii: S0046-8177(15)00003.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ovarian Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: